The Valley Desk

NCT04452591 · Interventional trial

Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

Overall registry status Active not recruiting

Phase 3

Conditions High-grade Ta/ T1 Papillary Disease Bladder Cancer, Non Muscle Invasive Bladder Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov